NITRIC for Pulmonary hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 551 adverse event reports in the FDA FAERS database where NITRIC was used for Pulmonary hypertension.
Most Reported Side Effects for NITRIC
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| No adverse event | 771 | 25.1% | 0 | 0 |
| Device malfunction | 553 | 18.0% | 2 | 0 |
| Device issue | 424 | 13.8% | 21 | 0 |
| Underdose | 398 | 13.0% | 3 | 0 |
| Product use issue | 332 | 10.8% | 177 | 19 |
| Death | 314 | 10.2% | 314 | 3 |
| Drug ineffective | 192 | 6.3% | 65 | 135 |
| Product use in unapproved indication | 190 | 6.2% | 119 | 12 |
| Oxygen saturation decreased | 169 | 5.5% | 39 | 2 |
| Off label use | 166 | 5.4% | 58 | 69 |
| Condition aggravated | 122 | 4.0% | 65 | 19 |
| Device delivery system issue | 122 | 4.0% | 2 | 0 |
| Device failure | 112 | 3.7% | 8 | 0 |
| Respiratory failure | 79 | 2.6% | 40 | 11 |
| Covid-19 | 62 | 2.0% | 59 | 4 |
Other Indications for NITRIC
Product used for unknown indication (876)
Covid-19 (114)
Newborn persistent pulmonary hypertension (96)
Hypoxia (88)
Acute respiratory distress syndrome (62)
Respiratory failure (56)
Pulmonary arterial hypertension (43)
Persistent foetal circulation (31)
Neonatal respiratory distress syndrome (22)
Oxygen saturation decreased (19)
Other Drugs Used for Pulmonary hypertension
AMBRISENTAN (18,885)
TREPROSTINIL (10,034)
MACITENTAN (5,228)
RIOCIGUAT (3,837)
SILDENAFIL (3,761)
SELEXIPAG (2,500)
EPOPROSTENOL (2,486)
TADALAFIL (2,430)
BOSENTAN (2,337)
ILOPROST (1,123)